FDA's Crawford cleared of affair

An inspector general's probe of a relationship between acting FDA commissioner Lester Crawford and a senior official of the agency concluded that he gave conflicting evidence in the investigation but could not corroborate if he was having an illicit affair. As a result, Republicans moved to push forward with his nomination as commissioner. Investigators said, however, that the unidentified woman told investigators that Crawford had provided improper assistance in gaining a promotion for her, which Crawford denied. Another FDA official contradicted Crawford's statement that he had endorsed the woman for the promotion, saying that he had, in fact, questioned her qualifications.

- read this article from The Washington Post

Sponsored by GenScript

Accelerate Biologics, Gene and Cell Therapy Product Development partnering with GenScript ProBio

GenScript ProBio is the bio-pharmaceutical CDMO segment of the world’s leading biotech company GenScript, proactively providing end-to-end service from drug discovery to commercialization with professional solutions and efficient processes to accelerate drug development for customers.

Suggested Articles

NYC’s outstanding talent and funding, the city is rich with life science real estate offerings across the five boroughs.

Sutro Biopharma’s lead antibody-drug conjugate shrank tumors in 13% of patients with ovarian cancer who had tried a median of six other treatments.

Immuno-oncology biotech Silverback Therapeutics has more than doubled its original IPO hopes.